Medtronic Reports Strongest Annual Revenue Growth in a Decade
Medtronic reported $36.4 billion in revenue for fiscal year 2026, marking an 8.4% YoY increase and the strongest annual growth in ten years. The company's cardiovascular segment led with a 12% rise to $13.98 billion, while Q4 results exceeded analyst expectations, boosting its stock price over 5%. Medtronic expects FY27 organic revenue growth between 6.75% and 7.25%, with earnings per share projected at $5.90–$6.00.
Tickers: $MDT
Topics: financial_performance medical_devices revenue_growth